Your browser doesn't support javascript.
loading
ZNRF3 and RNF43 cooperate to safeguard metabolic liver zonation and hepatocyte proliferation.
Sun, Tianliang; Annunziato, Stefano; Bergling, Sebastian; Sheng, Caibin; Orsini, Vanessa; Forcella, Pascal; Pikiolek, Monika; Kancherla, Venkatesh; Holwerda, Sjoerd; Imanci, Dilek; Wu, Fabian; Meylan, Ludivine Challet; Puehringer, Lea F; Waldt, Annick; Oertli, Mevion; Schuierer, Sven; Terracciano, Luigi M; Reinker, Stefan; Ruffner, Heinz; Bouwmeester, Tewis; Sailer, Andreas W; George, Elizabeth; Roma, Guglielmo; de Weck, Antoine; Piscuoglio, Salvatore; Lohmann, Felix; Naumann, Ulrike; Liberali, Prisca; Cong, Feng; Tchorz, Jan S.
Afiliação
  • Sun T; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: tlsun1983@gmail.com.
  • Annunziato S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Bergling S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Sheng C; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Orsini V; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Forcella P; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Pikiolek M; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Kancherla V; Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Holwerda S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Imanci D; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Wu F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Meylan LC; Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland; University of Basel, Basel, Switzerland.
  • Puehringer LF; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Waldt A; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Oertli M; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Schuierer S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Terracciano LM; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy; IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.
  • Reinker S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Ruffner H; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Bouwmeester T; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Sailer AW; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • George E; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Roma G; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • de Weck A; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Piscuoglio S; Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Lohmann F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Naumann U; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Liberali P; Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland; University of Basel, Basel, Switzerland.
  • Cong F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Tchorz JS; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: jan.tchorz@novartis.com.
Cell Stem Cell ; 28(10): 1822-1837.e10, 2021 10 07.
Article em En | MEDLINE | ID: mdl-34129813
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ubiquitina-Proteína Ligases / Fígado Limite: Animals Idioma: En Revista: Cell Stem Cell Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ubiquitina-Proteína Ligases / Fígado Limite: Animals Idioma: En Revista: Cell Stem Cell Ano de publicação: 2021 Tipo de documento: Article